Overview

Tech Summary

Promoter Holding

Posts

LALPATHLAB

20123456789,001234567895012345678980123456789.3012345678900123456789
+7.85 (+0.38%)
The current prices are delayed.Login/Sign Up to see live prices.
Previous Close: 2050.45
1D
5D
1M
3M
1Y
5Y
Today's low
2034
Today's high
2070
52 week low
1805.55
52 week high
3893
Volume
75072
About
Tech Summary
DMA(12)
₹2434.68
DMA(50)
₹2477.95
DMA(100)
₹2406.35
DMA(200)
₹2410.77
Fund Summary
Market Cap
₹17166.22 Cr.
Enterprise Value
₹16894.28 Cr.
No. of Shares
8.34
P/E
49.75
RoE
26.39
Debt/Equity
0.24
Valuations
PE Chart
455055606570
PB Chart
12141618
Promoter Holdings
Public : 14.5%
FII : 23.44%
DII : 6.83%
Promoter : 55.23%
Others : 0%
Charts
Debt/Equity
0.000.050.100.150.20
Mar, 2018Mar, 2019Mar, 2020Mar, 2021Mar, 2022
ROE vs ROCE
25303540
Mar, 2018Mar, 2019Mar, 2020Mar, 2021Mar, 2022
ROE
ROCE
Revenue vs Profitability (1000Cr.)
0.51.01.52.0
Mar, 2018Mar, 2019Mar, 2020Mar, 2021Mar, 2022
Revenue
Profit
Margins(%)
15202530
Mar, 2018Mar, 2019Mar, 2020Mar, 2021Mar, 2022
Net Margin
Gross Margin
About
Hero Img
Create your account on Frontpage
Join 2,00,000 Indian traders and discuss trades, strategies, news & views on any stock.
Stock Sentiments
88% Bullish
12% Bearish
17 live trades of Rs. 1,160,488.25
V
vikasshinde-HJDtk8Nqo
 
Reputation: 0 • 
Just now
LALPATHLAB FEB23 2100 CE
500 Qty (S) Exited₹2,425
K
kushaldebnath
 
Reputation: 0 • 
Just now
LALPATHLAB
1 Qty (S) Trade entered
Posts by FrontPage Users
Samarth-display-image
Reputation: 177  •  Jan 22 4:32 AM
1 Like
Comment
Share
Add a comment
Ankit-display-image
Reputation: 3,016  •  Jan 6 3:39 AM

Dr. Lal Path Labs should test 2000 and lower levels in 2 months. #LALPATHLAB
Chartbusters - chart - 21838793
Like
1 Comment
Share
Add a comment
SureStockLevel-display-image
Reputation: 2,236  •  Jan 2 1:14 PM

#LALPATHLAB sell below 2240 for target of 2220,2200,2180
Chartbusters - chart - 21045884
1 Like
Comment
Share
Add a comment
Daily Trade Byte-display-image
Reputation: 1,250  •  Dec 29, 2022 3:08 PM
1 Like
Comment
Share
Add a comment
SureStockLevel-display-image
Reputation: 2,236  •  Dec 28, 2022 2:21 PM

#LALPATHLAB sell below 2240 for target of 2220,2200,2180
Chartbusters - chart - 20480717
Like
Comment
Share
Add a comment
Logical Trader-display-image
Reputation: 626  •  Dec 27, 2022 11:45 AM

JUST WATCH LALPATHLAB ON DAILY TF VERY SOON GOOD MOVE POSSIBLE #LALPATHLAB
Chartbusters - chart - 20288234
2 Likes
Comment
Share
Add a comment
Logical Trader-display-image
Reputation: 626  •  Dec 23, 2022 5:21 PM
Like
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 29,855  •  Dec 22, 2022 3:11 PM
Stocks to buy: 5 short-term trading ideas by experts for 22 December 2022
Stocks to buy: 5 short-term trading ideas by experts for 22 December 2022
On the downside, the area between 18,133 and 18,080 represents a significant demand zone. As long as Nifty trades above 18,080, the general bullish texture will hold, but below 18,080, we can anticipate a short-term trend reversal,” Santosh Meena, Head of Research, Swastika Investmart Ltd., said.
The Economic Times
Like
Comment
Share
Add a comment
Logical Trader-display-image
Reputation: 626  •  Dec 22, 2022 7:24 AM
1 Like
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 29,855  •  Dec 21, 2022 7:36 PM
Diagnostic players rally up to 6% amid China covid surge
Diagnostic players rally up to 6% amid China covid surge
“The near-term market construct is not favourable for equities. The rising Covid cases in the US, Korea, Brazil, and China is an area of concern. The situation is dire in China. This might impact market sentiments,” V K Vijayakumar, Chief Investment Strategist at Geojit Financial Services said.
The Economic Times
Like
Comment
Share
Add a comment
Ashutosh Garudkar-display-image
Reputation: 537  •  Dec 21, 2022 2:57 PM

Sell Lalpathlab Below 2407

Sell - 2407
Sl - 2408.15
Tgt - 2%

Chartbusters - chart - 19563131
Like
1 Comment
Share
Add a comment
Stock Sangreh-display-image
Reputation: 7,262  •  Dec 18, 2022 7:46 PM

Triple bottom pattern formation:
Stock is at their strong support zone and Risk reward is favourable.
NOTE: Indicators are not supporting, Trade with strict SL.
Entry price: CMP
Target: 2450/2650
SL: closing below 2250

Disclaimer: I am not SEBI regis......read more
Chartbusters - chart - 19226758
Like
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 29,855  •  Dec 6, 2022 5:11 PM
Saurabh Mukherjea PMS fund nearly doubles investor wealth in 4 years
Saurabh Mukherjea PMS fund nearly doubles investor wealth in 4 years
In the highly concentrated long-term portfolio, almost all stocks have compounded their share prices at 15-30% annually demonstrating that stock selection contributed significantly to portfolio returns, the PMS fund said.
The Economic Times
Like
Comment
Share
Add a comment
R
Reputation: 544  •  Dec 3, 2022 2:30 AM
1 Like
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 29,855  •  Oct 25, 2022 2:31 PM
ETMarkets Smart Talk: IT & PSU banks could turn out to be the Dark Horse of Samvat 2079: Rahul Shah
ETMarkets Smart Talk: IT & PSU banks could turn out to be the Dark Horse of Samvat 2079: Rahul Shah
"The IT sector has been a pleasant surprise as far as the results are concerned. Top-line growth across most major companies has come in better than expected whereas attrition pressures have also eased, thus keeping both the growth as well as margins healthy. This, combined with attractive valuations, makes the sector a good bet from a 2-3 year perspective."
The Economic Times
Like
Comment
Share
Add a comment
Equity And Option Trader-display-image
Reputation: 46,972  •  Oct 21, 2022 1:18 PM

#LALPATHLAB in watchlist for today.
Will it again enter the box from which it gave break down previously?
Chartbusters - chart - 14491996
1 Like
Comment
Share
Add a comment
Sameer -display-image
Reputation: 8,783  •  Oct 20, 2022 4:06 PM

20-10-22
LALPATHLAB BUY OCT CE 2500 (Intraday)
only above 39.5

Like
2 Comments
Share
Add a comment
Trading Addict-display-image
Reputation: 26,261  •  Oct 16, 2022 7:27 PM

Dr Lalpath Lab For INTRADAY tomorrow
Date -17th oct 22
Timeframe-15 minutes
Sell below 2368 and target 2329
Buy above 2421 and traget 2450
#NIFTY50
Chartbusters - chart - 14100554
15 Likes
Comment
Share
Add a comment
Gann Trader-display-image
Reputation: 1,241  •  Oct 12, 2022 5:28 PM

🔥 Hero or Zero call 🔥

#LALPATHLAB ......Buy 2600 CE.......@13.20.............Trgt Open..........
Like
Comment
Share
Add a comment
Stock Sangreh-display-image
Reputation: 7,262  •  Oct 11, 2022 10:42 PM

Stocks to watch for sell:
1. Stock just breaks its previous support of 2270 level.
2. Stock is below 40 RSI.
3. TSI crosses below 0 line.
4. Stock is traded below its all 20,50,200 DMA.
Entry Price: 2260-2280
Target: 2100/2030
SL: 2300
#InvestingUniversity #Investme......read more
Chartbusters - chart - 13810873
1 Like
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 29,855  •  Sep 29, 2022 12:53 PM
Trade Spotlight | What should you do with India Cements, Dr Lal PathLabs, Glenmark Pharma on Thursday?
Trade Spotlight | What should you do with India Cements, Dr Lal PathLabs, Glenmark Pharma on Thursday?
Dr Lal PathLabs shares gained 1.7 percent to Rs 2,694.35, continuing uptrend for the seventh consecutive session. It has seen formation of bullish candle on the daily charts with higher high higher low formation for seven straight sessions, and has given a breakout of downward sloping resistance trend line adjoining April 8 and August 26.
Moneycontrol
Like
Comment
Share
Add a comment
MediTrading-display-image
Reputation: 726  •  Sep 19, 2022 5:03 PM

#LALPATHLAB - With Pharma companies in the weakening, #LALPATHLAB seems a good sell at current levels. All Levels mentioned don the chart as well.

Sell: CMP 2290

SL: 2520

Target: 2000
Chartbusters - chart - 12656906
1 Like
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 29,855  •  Sep 13, 2022 4:41 PM
Hot Stocks: Global brokerages on HDFC Life, Dr Lal PathLabs and Emami
Hot Stocks: Global brokerages on HDFC Life, Dr Lal PathLabs and Emami
The global investment bank expects Emami's growth to recover from H2FY23 after a very high base. Margin pressures will persist in the near term, it said. It marginally lowered FY23/24/25 EPS by 2-3 per cent. Emami trades at 26x FY24 earnings ~40 per cent discount to the peers, said the note.
The Economic Times
Like
Comment
Share
Add a comment
MycallsTrading-display-image
Reputation: 16  •  Sep 8, 2022 5:23 AM
1 Like
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 29,855  •  Sep 6, 2022 1:41 PM
Stocks in the news: Dreamfolks Services, Dixon Tech, Cipla, Adani Ports and Reliance Power
Stocks in the news: Dreamfolks Services, Dixon Tech, Cipla, Adani Ports and Reliance Power
The company is pivoting from a prescription manufacturing service to an original device manufacturer (ODM) for smart TVs, having acquired sub-licensing rights for Google TV and Android TV from Google. The rights, announced by Dixon on Monday, will enable the firm to both design and manufacture smart LED TVs for third-party brands.
The Economic Times
Like
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 29,855  •  Aug 31, 2022 6:06 AM
Dr Lal pulls up its socks as competition mounts
Dr Lal pulls up its socks as competition mounts
Gurgaon-headquartered Dr Lal PathLabs and other diagnostic chains are feeling the heat due to the big drop in demand for Covid-19 testing, competition intensifying with the entry of e-pharmacies, web aggregators and pharma companies into diagnostics, resulting in a price war at a time when inflation pressure is high.
The Economic Times
Like
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 29,855  •  Aug 31, 2022 6:01 AM
Dr Lal PathLabs pulls up its socks as competition mounts
Dr Lal PathLabs pulls up its socks as competition mounts
Gurgaon-headquartered Dr Lal PathLabs and other diagnostic chains are feeling the heat due to the big drop in demand for Covid-19 testing, competition intensifying with the entry of e-pharmacies, web aggregators and pharma companies into diagnostics, resulting in a price war at a time when inflation pressure is high.
The Economic Times
Like
Comment
Share
Add a comment
Sameer -display-image
Reputation: 8,783  •  Aug 25, 2022 4:08 PM

25-08-22
LALPATHLAB BUY AUG FUT (Intraday)
only above @ 2546

Like
Comment
Share
Add a comment
TradePeCharcha-display-image
Reputation: 1,202  •  Aug 16, 2022 4:02 AM
Like
1 Comment
Share
Add a comment
Nitesh Gupta-display-image
Reputation: 2,321  •  Aug 8, 2022 4:33 AM

#LALPATHLAB Seems to be moving out of downtrend. A clear pin bar formation is visible on daily chart. With a stop loss below 2270 , a positional long can be initiated.

The relative strength is recovering, a break out in the same will increase the momentum of the uptrend. See th......read more
3 Likes
Comment
Share
Add a comment
TradeAdda-display-image
Reputation: 59,128  •  Aug 5, 2022 4:24 PM

Lalpathlab
#update
2270 And 2250 to 2442 done T1 2420 150+ points running.
#TradeAdda #LALPATHLAB
Like
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 29,855  •  Aug 4, 2022 12:58 PM
Hot Stocks | Here is why you should bet on Dr Lal PathLabs and TCS for short term
Hot Stocks | Here is why you should bet on Dr Lal PathLabs and TCS for short term
Dr Lal PathLabs witnessed an ascending triangle pattern breakout on July 29 which was placed above Rs 2,250 levels in the daily time frame. After breakout, prices are showing a gradual upside movement in a small steep formation.
Moneycontrol
Like
Comment
Share
Add a comment
TradeAdda-display-image
Reputation: 59,128  •  Aug 2, 2022 3:07 PM
TradeAdda in LALPATHLAB
LALPATHLAB 2270 And Dips 2200 Sl 2120 Trg 2420 ...

Lalpathlab
2270 And Dip 2250 to 2370 100 point in one session
#TradeAdda #LALPATHLAB
1 Like
Comment
Share
Add a comment
TradeAdda-display-image
Reputation: 59,128  •  Aug 1, 2022 2:18 PM

LALPATHLAB
2270 And Dips 2200 Sl 2120 Trg 2420 2450
For Educational Purposes Only .
#TradeAdda #LALPATHLAB
Chartbusters - chart - 11122862
5 Likes
3 Comments
Share
Add a comment
NewsBot-display-image
Reputation: 29,855  •  Jul 28, 2022 9:36 PM
Dr Lal PathLabs Q1 Results: Net profit dips 57% to Rs 58 crore
Dr Lal PathLabs Q1 Results: Net profit dips 57% to Rs 58 crore
The company had reported a net profit of Rs 134 crore in the April-June period of the last fiscal.Revenue from operations declined to Rs 503 crore in the period under review from Rs 607 crore a year ago, Dr Lal PathLabs said in a regulatory filing.
The Economic Times
Like
Comment
Share
Add a comment
Kishore kumar Ganta -display-image
Reputation: 4,740  •  Jul 28, 2022 1:25 PM
2 Likes
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 29,855  •  Jul 27, 2022 10:01 PM
Hurun power-list: Roshni Nadar Malhotra of HCL wealthiest woman with Rs 84K cr net worth, Nykaa's Falguni Nayar beats Biocon boss for richest self-made billionaire
Hurun power-list: Roshni Nadar Malhotra of HCL wealthiest woman with Rs 84K cr net worth, Nykaa's Falguni Nayar beats Biocon boss for richest self-made billionaire
Indra Nooyi is the richest professional manager with Rs 5K cr wealth.
The Economic Times
Like
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 29,855  •  Jul 25, 2022 7:11 AM
FMCG spices it up, pharma takes a shot at diagnostics
FMCG spices it up, pharma takes a shot at diagnostics
Ahmedabad-based drug major Torrent Pharma is reportedly set to foray into the diagnostics business, although a formal announcement is awaited. Last year, its Mumbai-based peer Lupin made an organic foray into the ₹70,000-crore sector. Mankind Pharma and Reliance Life Sciences are other large players that have entered the sector.
The Economic Times
Like
Comment
Share
Add a comment
Gaurav Shinde -display-image
Reputation: 1,367  •  Jul 16, 2022 8:13 PM

WEEKLY MARKET REPORT :-
Indian equity benchmark indices settled 1 percent lower for the week ended July 15 amid volatility, weak GDP data and rising global inflation, which fueled the fears of a further rate hike by central banks across the world......read more
2 Likes
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 29,855  •  Jun 14, 2022 1:21 AM
More than 800 active integrations on Ayushman Bharat Digital Mission: NHA
More than 800 active integrations on Ayushman Bharat Digital Mission: NHA
As per the ABDM website, more than 22.33 crore health IDs have been created, 62,182 health facilities registered, 14,840 doctors registered, more than 5.43 lakh downloads of the Health Records App has been done, 867 integrators are active out of which 40 of them have been successful.
The Economic Times
Like
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 29,855  •  Jun 7, 2022 8:38 PM
These 7 companies saw sales, profit growth exceeded 10% in each of the last 3 fiscals
These 7 companies saw sales, profit growth exceeded 10% in each of the last 3 fiscals
Three of them have turned multibaggers and Bloomberg’s consensus rating shows that all the seven stocks still have some steam left
Moneycontrol
Like
Comment
Share
Add a comment
Money Maatu With Vinay-display-image
Reputation: 6,555  •  Jun 6, 2022 3:45 PM
MoneyMaatuWithVinay in LALPATHLAB
#LALPATHLAB looking good 2160 2140 as SL Intraday
Like
Comment
Share
Add a comment
Money Maatu With Vinay-display-image
Reputation: 6,555  •  Jun 6, 2022 3:33 PM
MoneyMaatuWithVinay in LALPATHLAB
#LALPATHLAB looking good 2160 2140 as SL Intraday
Like
Comment
Share
Add a comment
Money Maatu With Vinay-display-image
Reputation: 6,555  •  Jun 6, 2022 3:31 PM
MoneyMaatuWithVinay in LALPATHLAB
#LALPATHLAB looking good 2160 2140 as SL Intraday
Like
Comment
Share
Add a comment
Money Maatu With Vinay-display-image
Reputation: 6,555  •  Jun 6, 2022 3:29 PM
Like
Comment
Share
Add a comment
Manish Ramani-display-image
Reputation: 291  •  Jun 6, 2022 2:50 PM

LALPATHLABS 2250 CE BUY ABOVE 85...

NOTE : I AM NOT SEBI REGISTERED . ITS ONLY MY PERSONAL VIEW AND ONLY FOR EDUCATION PURPOSE NOT FOR TRADE........AND ALL TRADES ARE FOR INTRADAY ONLY........
Like
Comment
Share
Add a comment
Load More Posts